RESUMO
OBJECTIVE: Blepharophimosis syndrome (BPES) is an autosomal dominant genetic condition resulting from heterozygous mutations in the FOXL2 gene and clinically characterized by an eyelid malformation associated (type I) or not (type II) with premature ovarian failure. The distinction between the two forms is critical for female patients, as it may allow to predict fertility and to plan an appropriate therapy. Identifying an underlying causative mutation is not always predictive of the clinical type of BPES since genotype-phenotype correlations are not yet fully delineated. Here, we describe the clinical and hormonal phenotypes of three female patients with BPES type 1 from two novel families, correlate their phenotypes with identified mutations, and investigate the effects of hormone replacement therapy (HRT). METHODS: Clinical, biochemical, and genetic evaluation were undertaken in all the patients and genotype-phenotype correlation was analyzed. The effects of substitutive hormonal therapy on secondary sexual characteristics development and induction of menarche were evaluated. RESULTS: All patients presented with primary amenorrhea or other signs of ovarian dysfunction. Two distinct mutations, a missense p.H104R change and an in-frame p.A222_A231dup10 duplication in the FOXL2 gene were identified. Observed phenotypes were not in accordance with the prediction based on the current genotype-phenotype correlations. HRT significantly improved secondary sexual characteristics development, as well as the induction of menarche. CONCLUSIONS: This study highlights the importance of early recognition of BPES and emphasizes the need of personalized therapy and follow-up in female patients carrying distinct FOXL2 mutations.
Assuntos
Amenorreia/etiologia , Blefarofimose/genética , Fatores de Transcrição Forkhead/genética , Duplicação Gênica , Mutação de Sentido Incorreto , Ovário/fisiopatologia , Insuficiência Ovariana Primária/etiologia , Anormalidades da Pele/genética , Anormalidades Urogenitais/genética , Adulto , Amenorreia/prevenção & controle , Substituição de Aminoácidos , Blefarofimose/tratamento farmacológico , Blefarofimose/fisiopatologia , Blefarofimose/cirurgia , Terapia Combinada , Análise Mutacional de DNA , Pálpebras/anormalidades , Feminino , Proteína Forkhead Box L2 , Estudos de Associação Genética , Terapia de Reposição Hormonal , Humanos , Itália , Menarca/efeitos dos fármacos , Ovário/efeitos dos fármacos , Linhagem , Insuficiência Ovariana Primária/prevenção & controle , Anormalidades da Pele/tratamento farmacológico , Anormalidades da Pele/fisiopatologia , Anormalidades da Pele/cirurgia , Anormalidades Urogenitais/tratamento farmacológico , Anormalidades Urogenitais/fisiopatologia , Anormalidades Urogenitais/cirurgia , Adulto JovemRESUMO
Mutations in the glucokinase (GCK) gene are the most frequent cause of maturity onset diabetes of the young (MODY) in Italy. We evaluated GCK mutations in 32 unrelated patients younger than 18 years who had been diagnosed with MODY. Eleven different GCK heterozygous mutations were identified in 22 (68.7%) of the 32 probands. Nine mutations were missense and two were nonsense. Three of these mutations (E17X, P59S and E372X) have not been described previously and were shown to be associated with hyperglycaemia. Several prediction methods suggested that the E17X and E372X mutations result in a premature truncated protein and that the P59S mutation is pathogenic. This idea was further supported by evidence suggesting that Proline 59 is a highly conserved amino acid residue and that the P59S mutation does not appear to be present in non-diabetic controls and in sequence variant databases. Furthermore, this mutation was found in six (27.3%) of the patients from the same geographical area, Gargano, pointing to the existence of a founder effect, which was confirmed by microsatellite analysis.
Assuntos
Diabetes Mellitus Tipo 2/genética , Proteínas Serina-Treonina Quinases/genética , Substituição de Aminoácidos , Códon sem Sentido , Diabetes Mellitus Tipo 2/fisiopatologia , Feminino , Efeito Fundador , Quinases do Centro Germinativo , Humanos , Itália , Masculino , Mutação de Sentido Incorreto , Linhagem , Prolina/genética , Prolina/metabolismoRESUMO
BACKGROUND: Congenital deletions affecting 3q11q23 have rarely been reported and only five cases have been molecularly characterised. Genotype-phenotype correlation has been hampered by the variable sizes and breakpoints of the deletions. In this study, 14 novel patients with deletions in 3q11q23 were investigated and compared with 13 previously reported patients. METHODS: Clinical data were collected from 14 novel patients that had been investigated by high resolution microarray techniques. Molecular investigation and updated clinical information of one cytogenetically previously reported patient were also included. RESULTS: The molecular investigation identified deletions in the region 3q12.3q21.3 with different boundaries and variable sizes. The smallest studied deletion was 580 kb, located in 3q13.31. Genotype-phenotype comparison in 24 patients sharing this shortest region of overlapping deletion revealed several common major characteristics including significant developmental delay, muscular hypotonia, a high arched palate, and recognisable facial features including a short philtrum and protruding lips. Abnormal genitalia were found in the majority of males, several having micropenis. Finally, a postnatal growth pattern above the mean was apparent. The 580 kb deleted region includes five RefSeq genes and two of them are strong candidate genes for the developmental delay: DRD3 and ZBTB20. CONCLUSION: A newly recognised 3q13.31 microdeletion syndrome is delineated which is of diagnostic and prognostic value. Furthermore, two genes are suggested to be responsible for the main phenotype.
Assuntos
Deleção Cromossômica , Cromossomos Humanos Par 3 , Deficiências do Desenvolvimento/genética , Fácies , Genitália Masculina/anormalidades , Transtornos do Crescimento/genética , Deficiências do Desenvolvimento/diagnóstico , Feminino , Estudos de Associação Genética , Humanos , Masculino , Proteínas do Tecido Nervoso/genética , Receptores de Dopamina D3/genética , Síndrome , Fatores de Transcrição/genéticaRESUMO
Cystinuria is a classic heritable aminoaciduria that involves the defective transepithelial transport of cystine and dibasic amino acids in the kidney and intestine. Six missense mutations in the human rBAT gene, which is involved in high-affinity transport of cystine and dibasic amino acids in kidney and intestine, segregate with cystinuria. These mutations account for 30% of the cystinuria chromosomes studied. Homozygosity for the most common mutation (M467T) was detected in three cystinuric siblings. Mutation M467T nearly abolished the amino acid transport activity induced by rBAT in Xenopus oocytes. These results establish rBAT as a cystinuria gene.
Assuntos
Sistemas de Transporte de Aminoácidos Básicos , Proteínas de Transporte/genética , Cromossomos Humanos Par 2 , Cistina/metabolismo , Cistinúria/genética , Genes Recessivos , Glicoproteínas de Membrana/genética , Adolescente , Adulto , Sequência de Bases , Transporte Biológico , Criança , Mapeamento Cromossômico , Cistinúria/metabolismo , Análise Mutacional de DNA , Primers do DNA , Feminino , Genes , Homozigoto , Humanos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/ultraestrutura , Túbulos Renais/metabolismo , Túbulos Renais/ultraestrutura , Masculino , Microvilosidades/metabolismo , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Reação em Cadeia da PolimeraseRESUMO
In type I blepharophimosis/ptosis/epicanthus inversus syndrome (BPES), eyelid abnormalities are associated with ovarian failure. Type II BPES shows only the eyelid defects, but both types map to chromosome 3q23. We have positionally cloned a novel, putative winged helix/forkhead transcription factor gene, FOXL2, that is mutated to produce truncated proteins in type I families and larger proteins in type II. Consistent with an involvement in those tissues, FOXL2 is selectively expressed in the mesenchyme of developing mouse eyelids and in adult ovarian follicles; in adult humans, it appears predominantly in the ovary. FOXL2 represents a candidate gene for the polled/intersex syndrome XX sex-reversal goat.
Assuntos
Anormalidades Múltiplas/genética , Doenças Palpebrais/genética , Mutação , Doenças Nasais/genética , Adulto , Sequência de Aminoácidos , Animais , Sequência de Bases , Blefarofimose/genética , Blefaroptose/genética , Criança , Segregação de Cromossomos , Cromossomos Humanos Par 3 , Códon sem Sentido , Proteínas de Ligação a DNA/genética , Pálpebras/embriologia , Feminino , Proteína Forkhead Box L2 , Fatores de Transcrição Forkhead , Duplicação Gênica , Humanos , Masculino , Camundongos , Dados de Sequência Molecular , Ovário/embriologia , Linhagem , ATPases Translocadoras de Prótons , Homologia de Sequência de Aminoácidos , Síndrome , Fatores de Transcrição/genéticaRESUMO
The autosomal dominant, giant-platelet disorders, May-Hegglin anomaly (MHA; MIM 155100), Fechtner syndrome (FTNS; MIM 153640) and Sebastian syndrome (SBS), share the triad of thrombocytopenia, large platelets and characteristic leukocyte inclusions ('Döhle-like' bodies). MHA and SBS can be differentiated by subtle ultrastructural leukocyte inclusion features, whereas FTNS is distinguished by the additional Alport-like clinical features of sensorineural deafness, cataracts and nephritis. The similarities between these platelet disorders and our recent refinement of the MHA (ref. 6) and FTNS (ref. 7) disease loci to an overlapping region of 480 kb on chromosome 22 suggested that all three disorders are allelic. Among the identified candidate genes is the gene encoding nonmuscle myosin heavy chain 9 (MYH9; refs 8-10), which is expressed in platelets and upregulated during granulocyte differentiation. We identified six MYH9 mutations (one nonsense and five missense) in seven unrelated probands from MHA, SBS and FTNS families. On the basis of molecular modelling, the two mutations affecting the myosin head were predicted to impose electrostatic and conformational changes, whereas the truncating mutation deleted the unique carboxy-terminal tailpiece. The remaining missense mutations, all affecting highly conserved coiled-coil domain positions, imparted destabilizing electrostatic and polar changes. Thus, our results suggest that mutations in MYH9 result in three megakaryocyte/platelet/leukocyte syndromes and are important in the pathogenesis of sensorineural deafness, cataracts and nephritis.
Assuntos
Transtornos Plaquetários/genética , Leucócitos/patologia , Proteínas Motores Moleculares , Mutação , Cadeias Pesadas de Miosina/genética , Alelos , Sequência de Aminoácidos , Animais , Transtornos Plaquetários/patologia , Catarata/genética , Galinhas , Cromossomos Humanos Par 22 , Cristalografia por Raios X , Citoplasma/metabolismo , Genótipo , Perda Auditiva Neurossensorial/genética , Humanos , Modelos Moleculares , Dados de Sequência Molecular , Músculo Liso/metabolismo , Mutação de Sentido Incorreto , Cadeias Pesadas de Miosina/química , Miosinas/química , Miosinas/genética , Nefrite/genética , Neutrófilos/patologia , Neutrófilos/ultraestrutura , Fenótipo , Conformação Proteica , Estrutura Terciária de Proteína , Homologia de Sequência de Aminoácidos , Síndrome , Trombocitopenia/genéticaRESUMO
Cystinuria (MIM 220100) is a common recessive disorder of renal reabsorption of cystine and dibasic amino acids. Mutations in SLC3A1, encoding rBAT, cause cystinuria type I (ref. 1), but not other types of cystinuria (ref. 2). A gene whose mutation causes non-type I cystinuria has been mapped by linkage analysis to 19q12-13.1 (Refs 3,4). We have identified a new transcript, encoding a protein (bo, +AT, for bo,+ amino acid transporter) belonging to a family of light subunits of amino acid transporters, expressed in kidney, liver, small intestine and placenta, and localized its gene (SLC7A9) to the non-type I cystinuria 19q locus. Co-transfection of bo,+AT and rBAT brings the latter to the plasma membrane, and results in the uptake of L-arginine in COS cells. We have found SLC7A9 mutations in Libyan-Jews, North American, Italian and Spanish non-type I cystinuria patients. The Libyan Jewish patients are homozygous for a founder missense mutation (V170M) that abolishes b o,+AT amino-acid uptake activity when co-transfected with rBAT in COS cells. We identified four missense mutations (G105R, A182T, G195R and G295R) and two frameshift (520insT and 596delTG) mutations in other patients. Our data establish that mutations in SLC7A9 cause non-type I cystinuria, and suggest that bo,+AT is the light subunit of rBAT.
Assuntos
Sistemas de Transporte de Aminoácidos Básicos , Proteínas de Transporte/genética , Cistinúria/genética , Mutação da Fase de Leitura , Glicoproteínas de Membrana/genética , Mutação de Sentido Incorreto , Sequência de Aminoácidos , Animais , Células COS , Cromossomos Humanos Par 19 , Cistinúria/etnologia , DNA Complementar/análise , Feminino , Humanos , Itália , Judeus , Líbia , Masculino , Modelos Biológicos , Dados de Sequência Molecular , América do Norte , Linhagem , Homologia de Sequência de Aminoácidos , Espanha , Distribuição TecidualRESUMO
Ganglioneuroma is a rare benign tumor originating from autonomic ganglia and is considered the benign counterpart of neuroblastoma. Ganglioneuromas may be present as an isolated finding and, rarely, in association with neurofibromatosis type 1 (NF1). However, ganglioneuromas of the cervical spine with intradural extension and multiple locations are extremely rare. We describe a 32-year-old woman with multiple ganglioneuromas of the cervical, dorsal and lumbar spine associated with a few café-au-lait spots and subcutaneous nodules. The patient lacked other NF1 stigmata, such as freckling, Lisch nodules and cutaneous neurofibromas. Although our patient did not fulfill the NF1 diagnostic criteria, molecular diagnosis revealed a pathogenic mutation in the NF1 gene. Approximately 30 patients affected by NF1 and ganglioneuromas have been reported: in all these individuals, NF1 diagnosis was made according to the clinical diagnostic criteria and no patients have molecular diagnosis. Therefore, this is the first case with multiple spinal ganglioneuromas associated with a pathogenic NF1 mutation.
Assuntos
Ganglioneuroma/genética , Neurofibromina 1/genética , Neoplasias da Coluna Vertebral/genética , Adulto , Feminino , Ganglioneuroma/patologia , Humanos , Mutação , Linhagem , Neoplasias da Coluna Vertebral/patologiaRESUMO
Using array comparative genome hybridisation (CGH) 41 de novo reciprocal translocations and 18 de novo complex chromosome rearrangements (CCRs) were screened. All cases had been interpreted as "balanced" by conventional cytogenetics. In all, 27 cases of reciprocal translocations were detected in patients with an abnormal phenotype, and after array CGH analysis, 11 were found to be unbalanced. Thus 40% (11 of 27) of patients with a "chromosomal phenotype" and an apparently balanced translocation were in fact unbalanced, and 18% (5 of 27) of the reciprocal translocations were instead complex rearrangements with >3 breakpoints. Fourteen fetuses with de novo, apparently balanced translocations, all but two with normal ultrasound findings, were also analysed and all were found to be normal using array CGH. Thirteen CCRs were detected in patients with abnormal phenotypes, two in women who had experienced repeated spontaneous abortions and three in fetuses. Sixteen patients were found to have unbalanced mutations, with up to 4 deletions. These results suggest that genome-wide array CGH may be advisable in all carriers of "balanced" CCRs. The parental origin of the deletions was investigated in 5 reciprocal translocations and 11 CCRs; all were found to be paternal. Using customized platforms in seven cases of CCRs, the deletion breakpoints were narrowed down to regions of a few hundred base pairs in length. No susceptibility motifs were associated with the imbalances. These results show that the phenotypic abnormalities of apparently balanced de novo CCRs are mainly due to cryptic deletions and that spermatogenesis is more prone to generate multiple chaotic chromosome imbalances and reciprocal translocations than oogenesis.
Assuntos
Deleção Cromossômica , Transtornos Cromossômicos/genética , Translocação Genética , Anormalidades Múltiplas/genética , Aborto Habitual/genética , Adulto , Pré-Escolar , Quebra Cromossômica , Transtornos Cromossômicos/patologia , Coloração Cromossômica , Feminino , Doenças Fetais/genética , Humanos , Hibridização in Situ Fluorescente , Recém-Nascido , Deficiência Intelectual/genética , Masculino , Hibridização de Ácido Nucleico , Oogênese , Fenótipo , Diagnóstico Pré-Natal , EspermatogêneseAssuntos
Conexinas/genética , Surdez/genética , Genes Dominantes , Mutação , Proteínas de Xenopus , Sequência de Aminoácidos , Animais , Sequência de Bases , Cromossomos Humanos Par 13 , Conexina 30 , Conexinas/química , Humanos , Camundongos , Dados de Sequência Molecular , Homologia de Sequência de Aminoácidos , Distribuição Tecidual , Xenopus/metabolismo , Proteína beta-1 de Junções ComunicantesRESUMO
BACKGROUND: Megakaryopoiesis represents a multi-step, often unclear, process leading to commitment, differentiation, and maturation of megakaryocytes (MKs) that release platelets. AIM: To identify the novel genes that might help to clarify the molecular mechanisms of megakaryocytopoiesis and be regarded as potential candidates of inherited platelet defects, global gene expression of hematopoietic lineages was carried out. METHODS: Human cord blood was used to purify CD34+ stem cells and in vitro expand CD41+ cells and burst-forming unit-erythroid (BFU-E). We investigated the expression profiles of these three hematopoietic lineages in the Affymetrix system and selected genes specifically expressed in MKs by comparing transcripts of the different lineages using the dchip and pam algorithms. RESULTS: A detailed characterization of MK population showed that 99% of cells expressed the CD41 antigen whereas 73% were recognizable as terminally differentiated fetal MKs. The profile of these cells was compared with that of CD34+ cells and BFU-E allowing us to select 70 transcripts (MK-core), which represent not only the genes with a well-known function in MKs, but also novel genes never detected or characterized in these cells. Moreover, the specific expression was confirmed at both RNA and protein levels, thus validating the 'MK-core' isolated by informatics tools. CONCLUSIONS: This is a global gene expression that for the first time depicts a well-characterized population of cord blood-derived fetal MKs. Novel genes have been detected, such as those encoding components of the extracellular matrix and basal membrane, which have been found in the cytoplasm of Mks, suggesting that new physiological aspects of MKs should be studied.
Assuntos
Sangue Fetal/citologia , Glicoproteína IIb da Membrana de Plaquetas/biossíntese , Trombopoese/fisiologia , Anticorpos Monoclonais/metabolismo , Antígenos CD34/biossíntese , Antígenos CD34/metabolismo , Células Precursoras Eritroides/metabolismo , Citometria de Fluxo , Humanos , Técnicas In Vitro , Microscopia de Fluorescência , Família Multigênica , Análise de Sequência com Séries de Oligonucleotídeos , Glicoproteína IIb da Membrana de Plaquetas/química , RNA/química , RNA/metabolismo , Reação em Cadeia da Polimerase Via Transcriptase ReversaAssuntos
Anormalidades Múltiplas/diagnóstico , Colestase/diagnóstico , Fissura Palatina/diagnóstico , Doenças Hematológicas/diagnóstico , Retinose Pigmentar/diagnóstico , Doenças Vestibulares/diagnóstico , Criança , Pré-Escolar , Proteínas de Ligação a DNA/genética , Face/anormalidades , Feminino , Seguimentos , Humanos , Proteínas de Neoplasias/genéticaRESUMO
OBJECTIVE: To clarify the genotype-phenotype correlation and elucidate the role of digenic inheritance in cystinuria. METHODS: 164 probands from the International Cystinuria Consortium were screened for mutations in SLC3A1 (type A) and SLC7A9 (type B) and classified on the basis of urine excretion of cystine and dibasic amino acids by obligate heterozygotes into 37 type I (silent heterozygotes), 46 type non-I (hyperexcretor heterozygotes), 14 mixed, and 67 untyped probands. RESULTS: Mutations were identified in 97% of the probands, representing 282 alleles (86.8%). Forty new mutations were identified: 24 in SLC3A1 and 16 in SLC7A9. Type A heterozygotes showed phenotype I, but mutation DupE5-E9 showed phenotype non-I in some heterozygotes. Type B heterozygotes showed phenotype non-I, with the exception of 10 type B mutations which showed phenotype I in some heterozygotes. Thus most type I probands carried type A mutations and all type non-I probands carried type B mutations. Types B and A mutations contributed to mixed type, BB being the most representative genotype. Two mixed cystinuria families transmitted mutations in both genes: double compound heterozygotes (type AB) had greater aminoaciduria than single heterozygotes in their family. CONCLUSIONS: Digenic inheritance is an exception (two of 164 families), with a limited contribution to the aminoaciduria values (partial phenotype) in cystinuria. Further mutational analysis could focus on one of the two genes (SLC3A1 preferentially for type I and SLC7A9 for type non-I probands), while for mixed probands analysis of both genes might be required, with priority given to SLC7A9.
Assuntos
Cistinúria/genética , Mutação , Sistemas de Transporte de Aminoácidos Básicos/genética , Sistemas de Transporte de Aminoácidos Neutros/genética , Análise Mutacional de DNA , Triagem de Portadores Genéticos , Genótipo , Humanos , FenótipoRESUMO
Transforming growth factor beta1 (TGF-beta1) is abundant in bone and is an important regulator of the osteoclastic-osteoblastic interaction (coupling). The sequence variation, 713-8delC in the TGF-beta1 gene has previously been found to be associated with very low bone mass in osteoporotic women and with increased bone turnover in both osteoporotic and normal women. The possible association of this polymorphism with bone mass and bone turnover has now been investigated in 256 postmenopausal Italian women. A significant association of TGF-beta1 with bone mass was detected in the populations. Subjects carrying the sequence variation 713-8delC (Tt) genotype showed a significantly lower bone mineral density (BMD) at the hip than those without sequence variation in the genotype (TT). Individuals carrying the tt genotype have a more severe osteoporosis (P=0.0001 vs. TT and Tt genotypes). The frequency of the fragility fractures was significantly lower in individuals with TT genotype than in those with the Tt and tt genotypes (X2=21.9; P=0.006). Furthermore a significant association was found between 713-8delC and bone turnover. The results suggest a strong evidence for an association among the 713-8delC allele of the TGF-beta1 gene and the femoral BMD, the prevalence of osteoporotic fractures, and finally a high bone turnover in a sample of Italian postmenopausal women.
Assuntos
Osteoporose Pós-Menopausa/genética , Polimorfismo Genético , Pós-Menopausa/fisiologia , Fator de Crescimento Transformador beta/genética , Idoso , Densidade Óssea , Feminino , Humanos , Itália , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/fisiopatologiaRESUMO
Pendred syndrome is an autosomal-recessive disorder characterized by congenital sensorineural hearing loss combined with goiter. This disorder may account for up to 10% of cases of hereditary deafness. The disease gene (PDS/SLC26A4) has been mapped to chromosome 7q22-q31 and encodes a chloride-iodide transport protein. Mutations in this gene are also a cause of non-syndromic autosomal recessive hearing impairment (DFNB4). We have analyzed the PDS/SLC26A4 gene in Spanish and Italian families and we have detected five new mutations (X871M, T132I, IVS1-2A>G, Y556H and 406del5).
Assuntos
Proteínas de Transporte/genética , Transtornos da Audição/genética , Proteínas de Membrana Transportadoras , Alelos , DNA/química , DNA/genética , Análise Mutacional de DNA , Saúde da Família , Genótipo , Bócio/complicações , Bócio/genética , Perda Auditiva Neurossensorial/complicações , Perda Auditiva Neurossensorial/genética , Humanos , Itália , Mutação , Fenótipo , Espanha , Transportadores de Sulfato , SíndromeRESUMO
Pendred syndrome is an autosomal-recessive disorder characterized by congenital sensorineural hearing loss combined with goiter. This disorder may account for up to 10% of cases of hereditary deafness. The disease gene (PDS/SLC26A4) has been mapped to chromosome 7q22-q31 and encodes a chloride-iodide transport protein. Mutations in this gene are also a cause of non-syndromic autosomal recessive hearing impairment (DFNB4). We have analyzed the PDS/SLC26A4 gene in Spanish and Italian families and we have detected five novel mutations (X781W, T132I, IVS2-2A>G, Y556H and 406del5).
Assuntos
Proteínas de Transporte/genética , Perda Auditiva Neurossensorial/genética , Proteínas de Membrana Transportadoras , Alelos , Processamento Alternativo/genética , DNA/química , DNA/genética , Análise Mutacional de DNA , Saúde da Família , Genótipo , Bócio/complicações , Bócio/genética , Perda Auditiva Neurossensorial/complicações , Humanos , Itália , Região do Mediterrâneo , Mutação , Mutação de Sentido Incorreto , Fenótipo , Deleção de Sequência , Espanha , Transportadores de Sulfato , SíndromeRESUMO
More than 200 Wilson disease (WD) disease-causing mutations have been defined to date. Missense mutations are largely prevalent while splice-site mutations are limited in number. Most reside in the splice donor or acceptor sites and only a minority are detected in splicing consensus sequences. Furthermore, only a few splicing mutations have been studied at the RNA level to date. In this study, using the RT-PCR method we performed the molecular characterization of four consensus splice-site mutations identified by DNA analysis in patients with WD. One of them, previously described 1707+3insT, occurred at position 3 in the donor splice site of intron 4, while the other three, 2122-8T>G, 2866-6T>G, and 3061-12T>A, are novel and occurred in the acceptor splice sites of introns 7, 12, and 13, respectively. Analysis revealed a prevalently abnormal splicing in the samples carrying the mutations compared to the normal controls. Comparison of RNA splicing with normal controls in liver and lymphocytes further suggests that abnormal splicing of the WD gene is also present and differentially regulated in normal tissues. The results produced in this study strongly suggest that DNA mutations residing in the consensus sequence of WD gene splice sites result in the WD phenotype by interfering with the production of the normal WD protein. Further studies are necessary to better quantify the amount of different transcripts produced by these mutations, and establish their correlation with the disease phenotype.
Assuntos
Adenosina Trifosfatases/genética , Processamento Alternativo/genética , Proteínas de Transporte de Cátions/genética , Sequência Consenso/genética , Mutação/genética , Splicing de RNA/genética , RNA Mensageiro/genética , Adolescente , Idade de Início , Criança , ATPases Transportadoras de Cobre , Análise Mutacional de DNA/métodos , Feminino , Degeneração Hepatolenticular/genética , Humanos , Masculino , Reação em Cadeia da Polimerase Via Transcriptase ReversaRESUMO
Congenital deafness accounts for about 1 in 1000 infants and approximately 80% of cases are inherited as an autosomal recessive trait. Recently, it has been demonstrated that connexin 26 (GJB2) gene is a major gene for congenital sensorineural deafness. A single mutation (named 35delG) was found in most recessive families and sporadic cases of congenital deafness, among Caucasoids, with relative frequencies ranging from 28% to 63%. We present here the analysis of the 35delG mutation in 3270 random controls from 17 European countries. We have detected a carrier frequency for 35delG of 1 in 35 in southern Europe and 1 in 79 in central and northern Europe. In addition, 35delG was detected in five out of 376 Jewish subjects of different origin, but was absent in other non-European populations. The study suggests either a single origin for 35delG somewhere in Europe or in the Middle East, and the possible presence of a carrier advantage together with a founder effect. The 35delG carrier frequency of 1 in 51 in the overall European population clearly indicates that this genetic alteration is a major mutation for autosomal recessive deafness in Caucasoids. This finding should facilitate diagnosis of congenital deafness and allow early treatment of the affected subjects.
Assuntos
Conexinas/genética , Surdez/congênito , Deleção de Sequência , Conexina 26 , DNA/análise , DNA/sangue , Análise Mutacional de DNA , Surdez/genética , Europa (Continente) , Feminino , Testes Genéticos , Heterozigoto , Humanos , Masculino , Mutação Puntual , Reação em Cadeia da PolimeraseRESUMO
Nail patella syndrome (NPS) or osteo-onychodysplasia, is an autosomal dominant disorder characterised by nail dysplasia, absent or hypoplastic patellae, iliac horns and nephropathy. Previous studies have demonstrated linkage of the nail patella locus to the ABO and adenylate kinase loci on human chromosome 9q34. Recently, informative recombination events placed the NPS locus within a 1-2 cM interval within D9S60 and the AK1 gene. We describe here linkage analysis performed in two large Italian pedigrees with 10 and 11 members affected, respectively. A set of highly informative markers have been analysed and the allele segregation in the two families confirmed the linkage to chromosome 9. The presence of three recombination events allows definition of the critical region with a centrometric boundary between markers D9S1881 and D9S1840 and a telomeric boundary between markers D9S315 and D9S290.
Assuntos
Ligação Genética , Síndrome da Unha-Patela/genética , Sistema ABO de Grupos Sanguíneos/genética , Adenilato Quinase/genética , Cromossomos Humanos Par 9 , Feminino , Humanos , Masculino , Linhagem , Recombinação GenéticaRESUMO
Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant condition consisting of congenital dysplasia of the eyelids with a reduced horizontal diameter of the palpebral fissures, droopy eyelids and epicanthus inversus. Two clinical entities have been described: type I and type II. The former is distinguished by female infertility, whereas the latter presents without other symptoms. Both type I and type II were recently mapped on the long arm of chromosome 3 (3q22-q23), suggesting a common gene may be affected. The centromeric and the telomeric limits of this region are well defined between loci D3S1316 and D3S1615, which reside approximately 5 cM apart. Here, we present the construction of a YAC contig spanning the entire BPES locus using 17 polymorphic markers, 2 STS and 28 ESTs. This region of approximately 5 Mb was covered by 31 YACs, and was supported by detailed FISH analysis. In addition, we have precisely mapped the propionyl-CoA carboxylase beta polypeptide (PCCB), the gene mutated in propionic acidemia, within this contig. Apart from providing a framework for the identification of the BPES gene, this contig will also be useful for the future identification of defects and genes mapped to this region, and for developing template resources for genomic sequencing.